La prevalencia del síndrome metabólico en mujeres postmenopáusicas
Cargando...
Fecha
2018
Autores
Urina-Jassir, Daniela
Urina-Jassir, Manuel
Urina-Triana, Miguel
Mantilla-Morrón, Mirary
Urina-Triana, Manuel
Galeano-Muñoz, Luisa
Título de la revista
ISSN de la revista
Título del volumen
Editor
Cooperativa servicios y suministros 212518 RS
Resumen
Introducción y Objetivos: El desarrollo del aumento de
la grasa central abdominal, de la alteración del perfil lipídico
y de la resistencia a la insulina encontrado en el
síndrome metabólico están mayormente presentes en la
menopausia. Conocer la prevalencia del SM en mujeres
postmenopáusicas en Barranquilla, permitirá desarrollar
estrategias futuras para disminuir su presencia y la de las
enfermedades cardiovasculares.
Material y Métodos: Estudio transversal, realizado en
Barranquilla, Colombia entre octubre a noviembre 2016,
en mujeres con edad laboral. El diagnóstico del SM se hizo
con al menos tres de los cinco criterios propuestos por
el consenso de la Federación Internacional de Diabetes,
del Instituto Nacional del Corazón, Pulmón y Sangre, de
la Asociación Americana del Corazón, de la Federación
Mundial del Corazón, de la Sociedad Internacional de
Aterosclerosis y de la Asociación Internacional para el Estudio
de la Obesidad.
Resultados: Se incluyeron 773 mujeres, 78,65% premenopaúsicas
(n=608) y 21,35% post- menopáusicas
(n=165). El 27,8% (n=46) de mujeres post-menopáusicas
tenían SM vs. 14,6% (n=89) de las pre-menopaúsicas, con
una diferencia estadísticamente significativa de p<0,0001
(Chi-cuadrado 15.7845).
Conclusiones: En las mujeres post-menopáusicas se manifestó
una mayor incidencia de SM cuando se compara
con las pre-menopaúsicas, por lo que se incrementa el
riesgo cardiovascular. Se sugiere que deberían ser tratadas
en forma temprana con el fin de reducir su mortalidad.
Introduction and Objectives: Menopause represents a transition in female reproductive life, which has been associated with the development of typical characteristics of metabolic syndrome (MetS). These include increased abdominal central fat, impaired lipid profile and insulin resistance. Awareness MetS and its prevalence in pre and post-menopausal women, will be useful in developing future strategies to reduce its presence and with-it cardiovascular disease. Material and methods: This was a cross-sectional study, conducted in Barranquilla, Colombia between October and November 2016, in women of working age. The diagnosis of MetS was made with at least three of the five criteria proposed by the consensus of the International Diabetes Federation, the National Heart, Lung and Blood Institute, the American Heart Association, the World Heart Federation, the International Society of Atherosclerosis and the International Association for the Study of Obesity. Results: A total of 773 women were enrolled in our study, from which 78.65% were pre-menopausal (n=608) and 21.35% post-menopausal (n=165). The presence of MetS was seen in 27.8% (n=46) of post-menopausal in comparison to 14.6 % (n=89) of the pre-menopausal women, representing a statistically significant difference (Chisquare 15.7845 p <0.0001). Conclusions: MetS has a higher prevalence in postmenopausal women when compared to pre-menopausal women. As MetS is present, cardiovascular risk increases. This population should be identified early in time in order to screen, prevent and reduce their mortality.
Introduction and Objectives: Menopause represents a transition in female reproductive life, which has been associated with the development of typical characteristics of metabolic syndrome (MetS). These include increased abdominal central fat, impaired lipid profile and insulin resistance. Awareness MetS and its prevalence in pre and post-menopausal women, will be useful in developing future strategies to reduce its presence and with-it cardiovascular disease. Material and methods: This was a cross-sectional study, conducted in Barranquilla, Colombia between October and November 2016, in women of working age. The diagnosis of MetS was made with at least three of the five criteria proposed by the consensus of the International Diabetes Federation, the National Heart, Lung and Blood Institute, the American Heart Association, the World Heart Federation, the International Society of Atherosclerosis and the International Association for the Study of Obesity. Results: A total of 773 women were enrolled in our study, from which 78.65% were pre-menopausal (n=608) and 21.35% post-menopausal (n=165). The presence of MetS was seen in 27.8% (n=46) of post-menopausal in comparison to 14.6 % (n=89) of the pre-menopausal women, representing a statistically significant difference (Chisquare 15.7845 p <0.0001). Conclusions: MetS has a higher prevalence in postmenopausal women when compared to pre-menopausal women. As MetS is present, cardiovascular risk increases. This population should be identified early in time in order to screen, prevent and reduce their mortality.
Descripción
Palabras clave
Síndrome metabólico, Post-menopausia, Edad laboral, Metabolic syndrome, Post-menopausal, Working age